Objective To compare the efficacy of covid-19 vaccines between immunocompromised and
immunocompetent people. Design Systematic review and meta-analysis. Data sources …

Background Available data show that COVID-19 vaccines may be less effective in
immunocompromised populations, who are at increased risk of severe COVID-19 …

CoronaVac, an inactivated SARS-CoV-2 vaccine, has been approved for emergency use in
several countries. However, its immunogenicity in immunocompromised individuals has not …

Objectives The treatment for COVID-19 often utilizes immune-modulating drugs. These
drugs are also used in immune mediated inflammatory diseases (IMIDs). We performed a …

Abstract The Elecsys® Anti-SARS-CoV-2 S immunoassay (Roche Diagnostics International
Ltd, Rotkreuz, Switzerland) has been developed for the detection of antibodies to the severe …

COVID-19 vaccines are indispensable, with the number of cases and mortality still rising,
and currently no medicines are routinely available for reducing morbidity and mortality, apart …

An unprecedented global pandemic caused by a novel coronavirus named SARS-CoV-2
has created a severe healthcare threat and become one of the biggest challenges to human …

Objectives We aimed to assess the short-term effectiveness of COVID-19 vaccines among
immunocompromised patients to prevent laboratory-confirmed symptomatic COVID-19 …

Background Immune responses on SARS-CoV-2 vaccination in patients receiving anti-
CD20 therapies are impaired but vary considerably. We conducted a systematic review and …

Objective To evaluate the effect on immunogenicity and safety of 2-week methotrexate
(MTX) discontinuation after each dose of the Sinovac-CoronaVac vaccine versus MTX …